Development and implementation of tactical market entry plans for early-stage startup companies. Identify, develop and lead strategies to penetrate major target markets via key partnerships and KOL's. Closed large multi-million dollar capital equipment deals with biopharma accounts. Negotiate and execute deal structures for clinical studies and out-licensing agreements.

Responsible for leveraging ATCC’s extensive capabilities, product and service portfolio outside the core academic
research markets to extend the company’s reach and accelerate revenue growth and profitability.

Strategic management of sales of the BioLector and BioLector PRO microbioreactor systems in US and Canada. Built North American territory from the ground up, established extensive sales pipeline and grew business from $306K to $1.2 million in 2015; grew business from $1.2 million to $2.3 million in 2016; and to $2.9 million in 2017.

Capital equipment specialist focusing on sales of bioreactor/fermentation systems for lab and production-scale cultivation of mammalian and microbial cells

Sales account manager supporting consumable product line for medicinal chemistry and analytical sample prep.